[go: up one dir, main page]

PL361321A1 - Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands - Google Patents

Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands

Info

Publication number
PL361321A1
PL361321A1 PL03361321A PL36132103A PL361321A1 PL 361321 A1 PL361321 A1 PL 361321A1 PL 03361321 A PL03361321 A PL 03361321A PL 36132103 A PL36132103 A PL 36132103A PL 361321 A1 PL361321 A1 PL 361321A1
Authority
PL
Poland
Prior art keywords
molecules
conducting
products
active
clinical research
Prior art date
Application number
PL03361321A
Other languages
Polish (pl)
Inventor
Anna Bętkowska
Original Assignee
Anna Bętkowska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anna Bętkowska filed Critical Anna Bętkowska
Priority to PL03361321A priority Critical patent/PL361321A1/en
Publication of PL361321A1 publication Critical patent/PL361321A1/en
Priority to PCT/PL2004/000055 priority patent/WO2005008557A2/en
Priority to EP04748879A priority patent/EP1649280A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL03361321A 2003-07-17 2003-07-17 Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands PL361321A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL03361321A PL361321A1 (en) 2003-07-17 2003-07-17 Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands
PCT/PL2004/000055 WO2005008557A2 (en) 2003-07-17 2004-07-13 The method of conducting and interpretation of clinical trials
EP04748879A EP1649280A2 (en) 2003-07-17 2004-07-13 Method of conducting and interpretation of clinical trials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL03361321A PL361321A1 (en) 2003-07-17 2003-07-17 Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands

Publications (1)

Publication Number Publication Date
PL361321A1 true PL361321A1 (en) 2004-01-12

Family

ID=31974163

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03361321A PL361321A1 (en) 2003-07-17 2003-07-17 Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands

Country Status (3)

Country Link
EP (1) EP1649280A2 (en)
PL (1) PL361321A1 (en)
WO (1) WO2005008557A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611584D0 (en) * 1996-06-04 1996-08-07 Univ Edinburgh Neurotransmitters

Also Published As

Publication number Publication date
WO2005008557B1 (en) 2005-09-15
WO2005008557A3 (en) 2005-06-16
EP1649280A2 (en) 2006-04-26
WO2005008557A2 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
TWI372630B (en) Process for concentration of antibodies and therapeutic products thereof
GB0521942D0 (en) Methods and software for analysis of research publications
EP1606011A4 (en) Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
AU2003243151A8 (en) Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
FI20030287L (en) Novel use of polydextrose in an edible product, edible products containing polydextrose, and methods for incorporating polydextrose into edible products
AU2003267140A8 (en) Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis
EP1802756A4 (en) Probe of human papillomavirus and dna chip comprising the same
GB0426255D0 (en) Improvements in and relating to products for skin treatment
AU2003255612A8 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
PL361321A1 (en) Method of conducting and interpreting clinical research of products (molecules) active in receptor mechanism as exogenous ligands
AU2003287815A1 (en) Methods and products for representing and analyzing complexes of biological molecules
AU2003220966A1 (en) Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
PL1656954T3 (en) Therapeutic human albumin solutions with low prekallicrein activator (PKA) activity and process for obtaining them
GB2398381B (en) Improvements in and relating to apparatus and methods for materials investigation
IL166464A0 (en) Medicament and process for reducing alcohol and/ortobacco consumption
AU2002242806A1 (en) Means for extracting products to be analysed and applications thereof in diagnosis and analysis
GB0114639D0 (en) Improvements in and relating to analysis of DNA
EP1767648A4 (en) Method for measuring enzyme activity and column for use in measuring enzyme activity
AU2003240077A1 (en) Methods for the detection of polymorphisms in the human oatpf gene
GB2402060B (en) Improvements in and relating to support apparatus
EP1675963A4 (en) Microarray analysis of host and pathogen gene expression changes in vivo
ITMI20031856A1 (en) REINFORCED FRAME OF SUPPORT OF PRODUCTS IN GENERAL AND PROCEDURE FOR ITS REALIZATION.
GB0200062D0 (en) Improvements in and relating to apparatus and methods for materials investigation
GB0212583D0 (en) Support structure for molecules undergoing analysis
AU2004903988A0 (en) Improvements in skin care products

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)